Who are we?

Having started our trading operations in Australia in the 1950s, it was always BNM's objective to return to its roots one day.

Primacin (primaquine) became BNM's main registered product together with imipramine tablets and tetracycline eye ointment. It was in 2005 that a distribution opportunity presented in Australia and NZ which really kick-started started our journey home.

With the launch of the BNM Group trading name, BNM has now developed a portfolio of medicines to meet the healthcare needs of patients in Australia and NZ. This has been mainly achieved through in-licensing activities with highly committed partners.